DiaSorin S.p.A. (BIT: DIA) Stock Analysis & Fundamentals | ScreenerHero

Create free account

DIADiaSorin S.p.A.

BIT · IT · Healthcare · Diagnostics & Research · int.diasorin.com

67.76EUR-0.85%Mkt Cap: 3.65B $P/E: 25.671d ago

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiag…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Cheaper

P/B

Avg

Div Yield

Lower

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.65B $

Enterprise Value—

Revenue (TTM)1.27B $

Gross Profit840.73M $

Net Income (TTM)169.16M $

Revenue/Share23.97 USD

Last Price67.76 EUR

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees3.2K

CountryIT

SectorHealthcare

IndustryDiagnostics & Research

ISINIT0003492391

Valuation

P/E (Trailing)25.67

P/E (Forward)15.76

PEG1.60

EV/EBITDA—

EV/Revenue—

P/S2.87

P/B2.40

EPS (TTM)2.64

EPS (Forward)4.30

52W Range

52.3439% of range92.32

52W High92.32 EUR

52W Low52.34 EUR

Profitability

Gross Margin64.72%

Oper. Margin20.56%

EBITDA Margin30.28%

Profit Margin13.02%

ROE9.82%

ROA5.42%

Growth

Revenue Growth-8.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF372.57M $

CapEx (TTM)149.65M $

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.50

Current Ratio—

Quick Ratio—

Book Value/Sh28.25 EUR

Cash/Share—

Dividends

Fwd Div Rate1.300 EUR

Trail. Div Rate0.0000 EUR

Div. Yield1.86%

5Y Avg Yield1.12%

Payout Ratio45.55%

Ex-Div DateMay 18, 2026

Pay Date—

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)70.52 EUR

Upside (mean)+4.1%

Target Range58.00 EUR – 81.30 EUR

€58.00+4.1% to mean€81.30

# Analysts14

Ownership

Shares Out.49.58M

Float23.15M

Insiders57.56%

Institutions16.47%

Technical

SMA 5065.71 (+3.1%)

SMA 20067.81 (-0.1%)

Beta0.68

S&P 52W Chg20.05%

Avg Vol (30d)304.88K

Avg Vol (10d)247.68K

Technical Indicators

RSI (14)53.6

MACD0.0517

MACD Signal0.0697

MACD Hist.-0.0180

BB Upper72.30 EUR

BB Middle67.44 EUR

BB Lower62.57 EUR

BB Width14.43%

ATR (14)2.212 EUR

Vol Ratio (20d)0.87x